Global and Japan Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 08-Sep-2020
No. of pages: 99
Inquire Before Buying

Global Small Molecule Targeted Cancer Therapy Scope and Market Size

Small Molecule Targeted Cancer Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Monoclonal Antibodies

- Small Molecules

- Small Molecule Drug Conjugates

Market segment by Application, split into

- Lymphoma

- Melanoma

- Multiple Myeloma

- Breast Cancer

- Prostate Cancer

- Other Cancers

Based on regional and country-level analysis, the Small Molecule Targeted Cancer Therapy market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Small Molecule Targeted Cancer Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- OncoGenex Pharmaceuticals, Inc.

- Cytokinetics Inc.

- Hospira Inc.

- GlaxoSmithKline plc

- Boehringer Ingelheim GmbH

- Bayer HealthCare AG

- Abbott Laboratories

- ...

Global and Japan Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2015-2026)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Regions
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Market Size
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2015-2020)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2019
3.5 Key Players Small Molecule Targeted Cancer Therapy Area Served
3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type (2015-2026)
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2021-2026)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application (2015-2026)
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2015-2020)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
8.2 China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
8.3 China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
8.4 China Small Molecule Targeted Cancer Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
9.2 Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
9.3 Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
9.4 Japan Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
10.2 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020))
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Details
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.2.5 Cytokinetics Inc. Recent Development
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Details
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.3.5 Hospira Inc. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.5.5 Boehringer Ingelheim GmbH Recent Development
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Details
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.6.5 Bayer HealthCare AG Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.7.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Small Molecules
Table 5. Key Players of Small Molecule Drug Conjugates
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2015-2020)
Table 10. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Table 12. Small Molecule Targeted Cancer Therapy Market Market Trends
Table 13. Small Molecule Targeted Cancer Therapy Market Drivers
Table 14. Small Molecule Targeted Cancer Therapy Market Challenges
Table 15. Small Molecule Targeted Cancer Therapy Market Restraints
Table 16. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2015-2020)
Table 18. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019)
Table 19. Global Small Molecule Targeted Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size Share by Type (2015-2020)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 26. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2015-2020)
Table 27. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2021-2026)
Table 29. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 31. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 37. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 39. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 41. China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 42. China Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 43. China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 44. China Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 45. China Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million) (2015-2020)
Table 46. China Small Molecule Targeted Cancer Therapy Market Share by Region (2015-2020)
Table 47. Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 49. Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 51. Japan Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 53. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 55. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 59. OncoGenex Pharmaceuticals, Inc. Company Details
Table 60. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 61. OncoGenex Pharmaceuticals, Inc. Product
Table 62. OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 63. OncoGenex Pharmaceuticals, Inc. Recent Development
Table 64. Cytokinetics Inc. Company Details
Table 65. Cytokinetics Inc. Business Overview
Table 66. Cytokinetics Inc. Product
Table 67. Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 68. Cytokinetics Inc. Recent Development
Table 69. Hospira Inc. Company Details
Table 70. Hospira Inc. Business Overview
Table 71. Hospira Inc. Product
Table 72. Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 73. Hospira Inc. Recent Development
Table 74. GlaxoSmithKline plc Company Details
Table 75. GlaxoSmithKline plc Business Overview
Table 76. GlaxoSmithKline plc Product
Table 77. GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 78. GlaxoSmithKline plc Recent Development
Table 79. Boehringer Ingelheim GmbH Company Details
Table 80. Boehringer Ingelheim GmbH Business Overview
Table 81. Boehringer Ingelheim GmbH Product
Table 82. Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 83. Boehringer Ingelheim GmbH Recent Development
Table 84. Bayer HealthCare AG Company Details
Table 85. Bayer HealthCare AG Business Overview
Table 86. Bayer HealthCare AG Product
Table 87. Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 88. Bayer HealthCare AG Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 93. Abbott Laboratories Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Small Molecules Features
Figure 4. Small Molecule Drug Conjugates Features
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 6. Lymphoma Case Studies
Figure 7. Melanoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Other Cancers Case Studies
Figure 12. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Small Molecule Targeted Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2019
Figure 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2019
Figure 19. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 47. Cytokinetics Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 48. Hospira Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 50. Boehringer Ingelheim GmbH Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 51. Bayer HealthCare AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 52. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global and Japan Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 30-Nov-2020        Price: US 3900 Onwards        Pages: 131
    Global Small Cell Lung Cancer Therapeutics Scope and Market Size Small Cell Lung Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Cell Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. M......
  • Global Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 23-Nov-2020        Price: US 3660 Onwards        Pages: 115
    According to this study, over the next five years the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market will register a 5.4%% CAGR in terms of revenue, the global market size will reach $ 8982.8 million by 2025, from $ 7291.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics business, shared in Chapter 3. This report presents a comprehensive ove......
  • Global Circulating Tumor Cells (CTCS) and Cancer Stem Cells (CSCS) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 19-Nov-2020        Price: US 3400 Onwards        Pages: 117
    The Circulating Tumor Cells (CTCS) and Cancer Stem Cells (CSCS) market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Circulating Tumor Cells (CTCS) and Cancer Stem Cells (CSCS) market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Circulating Tumor Cells (CTCS) and Cancer Stem Cells (CSCS) market. ......
  • Circulating Tumor Cells Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 14-Nov-2020        Price: US 2800 Onwards        Pages: 118
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmen......
  • Global Cancer Immunotherapies Market Research Report 2020
    Published: 11-Nov-2020        Price: US 2900 Onwards        Pages: 117
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Cancer Immunotherapies market is segmented into - Monoclonal Antibodies (MABs) - Cancer Vaccines - Immun......
  • (COVID-19 Version) Global Actinic Keratosis Treatment Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 10-Nov-2020        Price: US 3000 Onwards        Pages: 91
    Summary The report forecast global Actinic Keratosis Treatment market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Actinic Keratosis Treatment industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Actinic Kera......
  • (COVID-19 Version) Global Breast Cancer Monoclonal Antibodies Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 07-Nov-2020        Price: US 3000 Onwards        Pages: 141
    Summary The report forecast global Breast Cancer Monoclonal Antibodies market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Breast Cancer Monoclonal Antibodies industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the lead......
  • Global Actinic Keratosis Treatment Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 05-Nov-2020        Price: US 3400 Onwards        Pages: 130
    The Actinic Keratosis Treatment market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Actinic Keratosis Treatment market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Actinic Keratosis Treatment market. The report focuses on well-known providers in the global Actinic Keratosis Treatment industry, m......
  • Global Glioblastoma Multiforme Treatment Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 03-Nov-2020        Price: US 3400 Onwards        Pages: 115
    The Glioblastoma Multiforme Treatment market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Glioblastoma Multiforme Treatment market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Glioblastoma Multiforme Treatment market. The report focuses on well-known providers in the global Glioblastoma Multifor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs